Strides Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE939A01011
  • NSEID: STAR
  • BSEID: 532531
INR
1,005.00
-2.05 (-0.2%)
BSENSE

Aug 10

BSE+NSE Vol: 1.54 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 688428,
    "name": "Strides Pharma",
    "stock_name": "Strides Pharma",
    "full_name": "Strides Pharma Science Ltd",
    "name_url": "stocks-analysis/strides-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,005.00",
    "chg": -2.05,
    "chgp": "-0.2%",
    "dir": -1,
    "prev_price": "1,007.05",
    "mcapval": "9,251.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532531,
    "symbol": "STAR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE939A01011",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "1.54 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/strides-pharma-688428-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Strides Pharma Science Q1 PAT rises 56.7% to 165.5 cr",
        "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOYktqckJ0SFdIY2ZvZW5MdTVLS2ZHYWtkWkhvczd0Z1BZWDdnRllha2M4UWtwaTVrdDNBOHRuVGZsVmNTYlB5bVFTb3Zmd0xqRUlMdVVfMHQ5Y25xM3pPcnFDeGJ0U3l0UUp2YU1mWk1QUm9GUlVkZ21renFkQldBM2c0dDJmX0Vsd2Nod1YxUmZUVGU2VkN4Vi1HNlFMaFdyVE5BcE1rV2kxNzhWLWpnWlVuVUdxQVQ20gG_AUFVX3lxTE9JWm5CQWcyYUlaMTJnWFpiY1VJRDRzTzBoSzRodTFiNEs5RUN5d3dObDNKZm15bm52Nk1mWUUyYUllMXdzVUpOSTdaUEtmejZMcmgxaVN4dVpqUUpxVnpiLTlGYlpCS1JKT0dGeTZ0SEZXM3RwUHBoS19kM0ZYU09xV2MxQzNkQU4wck5PNk56eTZCV1FGYW5odHRQRVdIUjZCeHNwVko1c2VmQ2tZZGpYTkZkLXdNQWRsV3hSSHhr?oc=5",
        "imagepath": "",
        "date": "2026-07-31 14:45:16",
        "description": "Strides Pharma Science Q1 PAT rises 56.7% to 165.5 cr  BusinessLine..."
      },
      {
        "title": "Strides Pharma Science Q1 PAT rises 56.7% to 165.5 cr",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-31 14:45:16",
        "description": "Strides Pharma Science Q1 PAT rises 56.7% to 165.5 cr  BusinessLine..."
      }
    ],
    "total": 2,
    "sid": "688428",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/strides-pharma-science-688428"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "03-Aug-2026",
      "details": "Transcript of Earnings Call pertaining to Unaudited Financial Results of the Company for the quarter ended June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "01-Aug-2026",
      "details": "Newspaper advertisement - Unaudited Financial Results for the quarter ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "31-Jul-2026",
      "details": "Audio Recording of Earnings Call dated July 31 2026 pertaining to unaudited financial results for Q1 FY27",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Strides Pharma Science Ltd has declared <strong>50%</strong> dividend, ex-date: 31 Jul 26",
          "dt": "2026-07-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

03-Aug-2026 | Source : BSE

Transcript of Earnings Call pertaining to Unaudited Financial Results of the Company for the quarter ended June 30 2026.

Announcement under Regulation 30 (LODR)-Newspaper Publication

01-Aug-2026 | Source : BSE

Newspaper advertisement - Unaudited Financial Results for the quarter ended June 30 2026

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

31-Jul-2026 | Source : BSE

Audio Recording of Earnings Call dated July 31 2026 pertaining to unaudited financial results for Q1 FY27

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Strides Pharma Science Ltd has declared 50% dividend, ex-date: 31 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available